These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4363061)

  • 1. The delayed and lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with use of killed Bordetella pertussis.
    Likhite VV
    Cancer Res; 1974 May; 34(5):1027-30. PubMed ID: 4363061
    [No Abstract]   [Full Text] [Related]  

  • 2. Rejection of mammary adenocarcinoma cell tumors and the prevention of progressive growth of incipient metastases following intratumor permeation with killed Bordetella pertussis.
    Likhite VV
    Cancer Res; 1974 Oct; 34(10):2790-4. PubMed ID: 4370327
    [No Abstract]   [Full Text] [Related]  

  • 3. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
    Likhite VV
    J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with intratumor injection of killed Corynebacterium parvum.
    Likhite VV; Halpern BN
    Cancer Res; 1974 Feb; 34(2):341-4. PubMed ID: 4810906
    [No Abstract]   [Full Text] [Related]  

  • 5. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG
    Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antitumor activity of Bordetella pertussis in two murine tumor models.
    Purnell DM; Kreider JW; Bartlett GL
    J Natl Cancer Inst; 1975 Jul; 55(1):123-8. PubMed ID: 169359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MA891--an established spontaneous mouse mammary adenocarcinoma cell line and its immunologic characteristics].
    Zhou Y; Luo L; Liu X; Gao P; Su Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):273-7. PubMed ID: 10453566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymic dependency of tumor-induced immunodepression.
    Rowland GF; Edwards AJ; Sumner MR; Hurd CM
    J Natl Cancer Inst; 1973 May; 50(5):1329-36. PubMed ID: 4351396
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of autochthonous grafts of spontaneous mammary tumor by induced allogeneic graft rejection mechanism.
    Tokuzen R; Nakahara W
    Cancer Res; 1973 Apr; 33(4):645-7. PubMed ID: 4696465
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
    Haskill S; Ritter F; Becker S
    J Immunol; 1980 Jul; 125(1):454-8. PubMed ID: 6247400
    [No Abstract]   [Full Text] [Related]  

  • 12. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Hager JC; Miller FR; Heppner GH
    Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 15. Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes.
    Musiani P; Modesti A; Brunetti M; Modica A; Vitullo P; Gulino A; Bosco MC; Colombo MP; Nanni P; Cavallo F
    Nat Immun; 1994; 13(2-3):93-101. PubMed ID: 8173240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multicellular tumor spheroid model. II. Characterization of the primary allograft response in unsensitized mice.
    Lord EM; Nardella G
    Transplantation; 1980 Feb; 29(2):119-24. PubMed ID: 6766584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to a TA3 tumor subline that grows in allogeneic hosts elicited by strain-specific TA3 tumor cells.
    Lippman MM; Venditti JM; Kline I; Elam DL
    Cancer Res; 1973 Apr; 33(4):679-84. PubMed ID: 4696468
    [No Abstract]   [Full Text] [Related]  

  • 18. Rejection of tumors and metastases in Fischer 344 rats following intratumor administration of killed Corynebacterium parvum.
    Likhite VV
    Int J Cancer; 1974 Nov; 14(5):684-90. PubMed ID: 4459281
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of abdominal transplanted mammary tumor on peritoneal fluid cytology in mice.
    Davis RH; Sackman JW; Kramer DL; Balin H
    Obstet Gynecol; 1975 Feb; 45(2):190-2. PubMed ID: 1118092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse.
    Hosokawa M; Orsini F; Mihich E
    Cancer Res; 1975 Oct; 35(10):2657-62. PubMed ID: 1157040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.